focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Hi Dibs61, acording to SimplyWall.St, only 11.3% of the company is held by the General Public, the top 25 shareholders hold 86% of the company. So it is difficult to get hold of shares, and when significant news comes, the share price should jump significantly.
From Linkedin:
Feedback Medical Ltd are joining the UK-Indian Healthcare Trade Mission (Feb 13-17th to #Delhi, #Mumbai and #Bengaluru to showcase Bleepa - a secure clinical grade communication platform and #Carelocker a patient centric data storage and image sharing solution.
Good find Oldtramp.... Sounds like Bleepa/Carelocker to me:
An exciting opportunity has become available within the QVH Community Diagnostic Centre for a Project and Delivery Manager to lead and support the project into the second year and beyond. This role involves the further development of a digital platform for communication between primary care and QVH, supporting patient through a breathlessness pathway, supported by clinical leads and a wider multidisciplinary team.
https://fbkmed.com/wp-content/uploads/2023/02/Interim-Report-2023-Published-on-07-February-2023.pdf
Lots of information in the full Interim Report, all looking very exciting to me with lots of near term news to expect regarding CDCs and the Carelocker App in India, looking forward to this afternoons Investor presentation.
"We remain extremely excited by our growth prospects and continue to target a number of opportunities. Importantly, we have numerous routes to market and increasing levels of visibility and look forward to providing the market with further updates in due course."
Another snippet, Carelocker has it's own website. though obviously early days...
https://carelocker.in/
Looks like revenue is already being generated. Hundreds of patients signed up to Carelocker.
From the Indian Bleepa Website:
“Since launching our collaboration with CareLocker at our Diagnostic Centre In Indore, we have seen hundreds of patients signing up for CareLocker to access their DICOM Images and Health Records Digitally. Patients can now view their medical data easily and securely on their own devices and will be able to quickly share them with consultants before appointments, benefiting patients and clinicians,”
Dr R K Sodani
Chairman & Managing Director
Sampurna Sodani Diagnostic Clinic
Interesting to note that when Tom is talking about the rollout of CDCs within the UK, he mentions that he expects the first 3 or 4 CDCs going live in 4-5 months time. Now the date of the presentation was 20th September 22, so this month could be pretty special. A further 33 CDC should then be rapidly rolled out throughout the rest of the year.
Anyone who is interested to learn more about Feedback, the last Investor Meet video is well worth watching. Also a good refresh to understand what is coming...
https://fbkmed.com/feedback-plc/reports-and-presentations/
From Nick Mayhew on Linkedin:
Our Chairman, @Prof Rory Shaw challenging the Panel at the #Healthcare World event at #arabhealth2023 Health around the importance of centralising data around a specific patient episode to ensure that multiple clinicians have a common view of a patient wherever they may be located (London, Riyadh, Dubai etc) - all to help expedite patient care.
Another, as yet untapped marketplace.
A reminder from the Fianal Results in September:
"With an expected 150 CDCs to be created, and an estimated total addressable market of over £90m, the CDC programme represents a huge opportunity for the Company, for which we are uniquely positioned to exploit, given our regulatory compliant user interface (Bleepa) and patient-centric data architecture (CareLocker) which, in combination, can connect multiple providers around an individual patient journey. Our pilot deployment at Sussex ICS has successfully delivered the first end-to-end symptom-based CDC pathway in the NHS and would not have been achievable without our digital infrastructure offering. This should drive adoption of our products at sites that hope to replicate the success of the Sussex programme."
"Strategically, regional cross-provider opportunities are of key importance to our future trajectory. The average contract value is considerably higher than a sale to an individual NHS trust, which requires a similar degree of customer development resource. It is also an area of low competition as no other provider can currently offer our combination of patient-centric data management and a regulated clinician interface, which gives us a large early mover advantage. Bleepa’s UKCA-marked image viewer remains a key USP given the requirement for image display within a regulatory compliant image viewer. We hope to achieve significant commercial traction following the reporting of the initial Sussex pilot results and evolution of the CDC programme as central funding comes online."
Well spotted Vascular: 2 year initial contract - £1.6M
Published: Mon 30 Jan 2023
Deadline: Wed 01 Mar 2023
Queen Victoria NHS Foundation Trust is looking to award a contract for the provision of a Digital Communication Platform for the Community Diagnostic Centre (CDC) along with the ongoing maintenance and support for 2 years with +1+1 options for extending. The primary aim of the digital platform requirement is to provide a way of delivering care, connecting teams flexibly over a distance and equipping them with the information they need to make informed clinical decisions.
Hi Vascular,
As a reminder, here's Adam Dennings biography fro the Feedback website:
Adam spent 25 years at Microsoft Corporation in various roles. From 2011-2017, he was a Partner Group Program Manager. In this role, he reported directly to the Corporate VP of the Windows platform, leading an international team of over 100 people and executing updates to Windows to deliver new customers. Before then, from 1999-2001, he served as an Assistant Technical Advisor to the Executive Office, presenting “demo days”, where he would demonstrate internal and external technology to Bill Gates and attending all of his product reviews.
He must be on the Board for these reasons........?
Hi Vascular,
Thanks for your research, much appreciated! I have not seen the Feedback article before, and wasn't aware of Bleepa's compatability with Teams. I don't believe it's been mentioned by Tom before, but in my opinion it's an important link as Teams is used throughout the NHS, so being able to use Bleepa within the Teams environment as a CE certified tool creates a valueable combination.
From the article:
"Feedback Medical has partnered up with Microsoft to integrate its pioneering technology into the Teams platform and offers a world-class, holistic solution for medical communications.Bleepa is an in-app extension of Microsoft Teams and will be accessible through the Teams single sign on, meaning that clinicians will only need one login credential to access both systems. Teams enables 1:1 or group video and audio consultations alongside Bleepa and notifications to improve patient case management.
Bleepa will allow Teams to be used flexibly for:
• Virtual ward rounds
• Inpatient/outpatient referrals
• Multidisciplinary meetings (MDTs)
• Clinical second opinion services or senior clinician engagement for junior doctors"
From the previous trading statement:
As has been referenced in various trading statements, in the first half of 2021, the business received a commitment from a second US end customer for conversion to our biodegradable coffee filtration material. Whilst the end customer has been purchasing regularly in the last eighteen months at limited levels, the subsequent expected acceleration of revenues has been constrained by various matters. These constraints are now clearing and a substantial increase in orders for this customer has been received for delivery in Q4 2022. Fulfilment of these orders in the coming weeks is expected to double the year's revenues from this source. Further, there are reasonable grounds to believe that this increased offtake rate will persist into 2023.
From the Bleepa website:
https://bleepa.com/a-conversation-with-sharon-donald-sales-manager